Clinical Trials Insight: 700029364
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2007
At a glance
- Drugs Cyclophosphamide; IDD 3
- Indications Malignant melanoma
- Focus Therapeutic Use
- 19 Dec 2007 New trial record.
- 14 Dec 2007 Initiation of this trial is expected in the next 60 days.